Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Edwards Lifesciences Corporation (EW) had Normalized Income after Taxes of $345.00M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
$1.39B |
|
$385.60M |
|
$292.20M |
|
$1.09B |
|
$1.07B |
|
$312.60M |
|
$77.50M |
|
$390.10M |
|
$390.10M |
|
$345.00M |
|
$345.00M |
|
$384.30M |
|
|
Normalized Income after Taxes |
$345.00M |
$312.60M |
|
-- |
|
589.80M |
|
590.50M |
|
$0.65 |
|
$0.65 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|